Delivery Order SPE2DB20D1102-SPE2DB24FC6NZ

Award Date 6/20/24
Potential Completion Date 6/21/24
Potential Value $6.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) has awarded a delivery order contract valued at $4,161.12 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) 3mL medication. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between DLA Troop Support Medical and AmerisourceBergen, which provides a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The contract...
The U.S. government's Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Ozempic, a 1 mg/dose (4 mg/3 ml) 3 ml medication, valued at $9,063.52. The contract has a firm fixed price and an ultimate completion date of December 20, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a $4,644.32 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml medication. The Firm Fixed Price contract has a ceiling value of $2,649.27 and a completion date of April 25, 2024. This award is under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, to provide Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. The contract has a potential value of $10,811.92 and a completion date of February 16, 2024. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 through December 31, 2025, which serves as the primary vehicle...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $11,026.45 contract is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. This delivery order is part of a larger, single award indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA Troop Support Medical...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $5,158.28 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of Ozempic 1 mg/dose (4 mg/3 ml) 3ml, a prescription medication. The contract has an ultimate completion date of April 17, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with DLA Troop Support Medical, valued at...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. The firm fixed price contract is valued at $4,059.12 and has a completion date of February 20, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 with a performance period...
The Defense Logistics Agency (DLA) awarded a $38,245.40 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a large pharmaceutical distributor, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the agency to efficiently procure a comprehensive range of medical commodities to support...
The U.S. Defense Logistics Agency (DLA) awarded a $6,548.66 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical and medical products to military healthcare programs globally. The contract...
  • SPE2DB20D1102
    Indefinite Delivery Contract
  • SPE2DB20D1102-SPE2DB24FC6NZ
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, to provide Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. The contract has a ceiling value of $6,242.76 and a completion date of June 21, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC enables DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies to support military treatment programs and facilities worldwide. This specific contract award was made on a full and open competition basis without any set-aside designations.

Generated 9/19/24, 9:05 AM